For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Get a Quote
Glibenclamide Manufacturer

We are diabetes bulk drug manufacturer named Glibenclamide. The CAS number of Glibenclamide is 10238-21-8.
Glibenclamide is a sulphonylurea also known as an oral hypoglycaemic. It is used in treatment of type 2 diabetes mellitus. It is used to control blood sugar level in people with type 2 diabetes. It is used when exercise and diet can’t control blood sugar levels. It treats type 2 diabetes by controlling blood sugar level.

Cadila Pharmaceuticals is a USFDA approved major pharmaceutical company based in India. It’s Active Pharmaceutical Ingredients (APIs) plant is approved by USFDA. Cadila Pharmaceuticals Limited is one of leading FDA approved APIs manufacturer. We offer Active Pharmaceutical Ingredients (APIs) of the highest quality at inexpensive rate.

Cadila Pharmaceuticals Ltd. is a proven leader in synthesizing APIs. We are major Glibenclamide manufacturer and supplier. We supply Glibenclamide locally as well as to the Latin countries like; Brazil, Argentina, Uruguay, Venezuela, Chile, Ecuador, Peru etc.

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals